ZVRA News & Events

Zevra Therapeutics announced that the Company has executed an exclusive expanded access distribution agreement with Uniphar. The agreement enables Niemann-Pick Disease Type C patients to access MIPLYFFA, for reimbursed named patient supply in select territories outside of Europe.

Zevra Therapeutics announced the appointment of Alicia Secor to the Company's Board of Directors. The Company announced the retirement of director Wendy Dixon, PhD, effective today.

Zevra Therapeutics announced that its CFO and treasurer, R. LaDuane Clifton, will be stepping down from his position with the company, effective December 31 in order to pursue other professional opportunities. The company has initiated a search to identify its next chief financial officer.